Background & Objective: The incidence of non-small cell lung cancer (NSCLC) has been rising over the past several decades. Despite various therapeutic regimens and modern diagnostic techniques are developed, NSCLC still have an extremely poor prognosis due to drug resistance. Therefore, it is critical to find a novel precise diagnosis and effective treatment approach for NSCLC patients. MicroRNAs (MiRNAs) are a class of 18-25nt non-coding small RNAs, which have been shown to be involved profoundly in the pathogenesis such as cellular proliferation, differentiation, development, apoptosis and tumorigenesis in many human tumors including of NSCLC. We reviewed existing research literature regarding correlations between miRNAs and their target’s response to anticancer treatment, and summarized the recent findings between miRNAs and therapy availability in NSCLC.
CITATION STYLE
Lu, J., Zhan, Y., Feng, J., Luo, J., & Fan, S. (2018, March 10). MicroRNAs associated with therapy of non-small cell lung cancer. International Journal of Biological Sciences. Ivyspring International Publisher. https://doi.org/10.7150/ijbs.22243
Mendeley helps you to discover research relevant for your work.